Robert Trondl

2.1k citations
15 papers · 1.5k · 1 hit paper · h-index 14

Impact in

  • Oncology top 2%
    • Metal complexes synthesis and properties
    • Ferrocene Chemistry and Applications
    • Synthesis and Characterization of Heterocyclic Compounds
    • Click Chemistry and Applications
    • Synthesis and biological activity
    • Organometallic Compounds Synthesis and Characterization

Papers in

    • Metal complexes synthesis and properties 8
    • Click Chemistry and Applications 2
    • Synthesis and Characterization of Heterocyclic Compounds 2

Robert Trondl

15 papers receiving 1.5k citations

Robert Trondl's Hit Papers

NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application 2014 · 588 citations
5880+4+8Years since publication100200300400500

Peers

Robert Trondl
Comparison fields: 5 of 83
  • Oncology 1.1k
  • Organic Chemistry 880
  • Inorganic Chemistry 295
  • Toxicology 28
  • Electronic, Optical and Magnetic Materials 106
Replace Ke-Bin Huang with:
Ke-Bin Huang China
Orsolya Dömötör Hungary
Mauro Coluccia Italy
Piedad del Socorro Murdoch United Kingdom
Lara Massai Italy
C. Scolaro Switzerland
Qiong Wu China
Isabel Gracia‐Mora Mexico
Tiziano Marzo Italy
Teresa Gianferrara Italy
Robert Trondl relative to Ke-Bin Huang China Ke-Bin Huang's profile →
Citations per field
00.5×1.5×2.1×
Ke-Bin Huang · 1×
Citations per year

Countries citing papers authored by Robert Trondl

Since Specialization
Citations

This map shows the geographic impact of Robert Trondl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Trondl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Trondl more than expected).

Fields of papers citing papers by Robert Trondl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Trondl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Trondl. The network helps show where Robert Trondl may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert Trondl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert Trondl Line = papers co-authored together Robert Trondl links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1
NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
Hit paper breakdown →
2014588
2 2009147
3 2011127
4 2012124
5 201698
6 200978
7 201266
8 201365
9 201262
10 200659
11 201543
12 201435
13 201526
14 201215
15 20141

About Robert Trondl

Robert Trondl is a scholar working on Oncology, Organic Chemistry, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Inorganic Chemistry, having authored 15 papers that have together received 1.5k indexed citations. Recurring topics across this work include Metal complexes synthesis and properties (8 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Click Chemistry and Applications (2 papers), Synthesis and Characterization of Heterocyclic Compounds (2 papers), Cancer therapeutics and mechanisms (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Crystal structures of chemical compounds (2 papers) and Autophagy in Disease and Therapy (2 papers). The work is most often cited by research in Oncology (1.1k citations), Organic Chemistry (880 citations), Inorganic Chemistry (295 citations), Toxicology (28 citations) and Electronic, Optical and Magnetic Materials (106 citations). Robert Trondl has collaborated with scholars based in Austria, Hungary and New Zealand. Frequent co-authors include Bernhard K. Keppler, Michael A. Jakupec, Christian R. Kowol, Walter Berger, Petra Heffeter, Vladimir B. Arion, Éva A. Enyedy, Tamás Kiss, Christian G. Hartinger and Irene Lichtscheidl. Their work appears in journals such as Investigational New Drugs, Inorganic Chemistry, Chemical Communications, Molecular Pharmacology and BMC Pharmacology and Toxicology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact